Total Voting Rights

RNS Number : 6701M
GlaxoSmithKline PLC
02 February 2009
 




Total Voting Rights and Capital


In conformity with Disclosure and Transparency Rule 5.6.1R, GlaxoSmithKline plc (“the Company”) hereby notifies the market of the following:


The Company's issued share capital as at 31 January 2009 consisted of 5,662,379,039 Ordinary shares of 25p each with voting rights, of which 474,194,158 Ordinary shares are held in Treasury.


Therefore, the total number of voting rights in the Company is 5,188,184,881. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Services Authority's Disclosure and Transparency Rules.




S M Bicknell

Company Secretary


2 February 2009



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TVRUUUPPPUPBGRP

Companies

GSK (GSK)
UK 100

Latest directors dealings